Table 1. Clinical characteristics and patient medications.
| Clinical characteristics | Study group (n=100) | Control group (n=25) | p |
|---|---|---|---|
| Male | 77 (77) | 19 (76) | 0.91 |
| Age (years) | 55±9 | 57±6 | 0.54 |
| Height (cm) | 169±7.5 | 171±9.7 | 0.48 |
| Weight (kg) | 80±12 | 77±14 | 0.29 |
| BMI (kg/m2) | 28±4 | 27±5 | 0.88 |
| Hypertension | 49 (49) | 14 (56) | 0.24 |
| Diabetes mellitus | 25 (25) | 7 (28) | 0.72 |
| Heart failure | 4 (4) | 1 (4) | 0.99 |
| Hyperlipidemia | 25 (25) | 8 (32) | 0.19 |
| Family history | 48 (48) | 11 (44) | 0.78 |
| Smoking | 57 (57) | 13 (52) | 0.42 |
| Myocardial infarction | 45 (45) | 12 (48) | 0.78 |
Data are expressed as mean±standard deviation or n (%). BMI: body mass index, ACEI: angiotensin converting enzyme inhibitors, ARB: angiotensin receptor blockers, ASA: acetylsalicylic acid